Impact of Teduglutide on Quality of Life Among Patients With Short Bowel Syndrome and Intestinal Failure

Keyphrases

• Quality of Life 100%
• Short Bowel Syndrome 100%
• Intestinal Failure 100%
• Teduglutide 100%
• Parenteral Support 54%
• Placebo 45%
• Support Volume 45%
• Related Quality of Life 27%
• Volume Constraint 18%
• Bowel 9%
• Adjusted Analysis 9%
• Subscale Scores 9%
• Volume Reduction 9%
• Generalized Estimating Equations 9%
• Baseline Characteristics 9%
• Disease Etiology 9%
• Quality of Life Impact 9%
• Item Rating 9%
• Inflammatory Bowel Disease [IBD] 9%
• Phase 3 Trial 9%
• Quality of Life Score 9%
• Trial Data 9%

Medicine and Dentistry

• Quality of Life 100%
• Patient with Short Bowel Syndrome 100%
• Teduglutide 100%
• Intestinal Failure 100%
• Short Bowel Syndrome 63%
• Placebo 45%
• Inflammatory Bowel Disease 27%
• Post-Hoc Analysis 9%
• Anatomical Concepts 9%
• Diseases 9%
• Etiology 9%